Rationale and design of the steroids in cardiac surgery trial

American Heart Journal

Volumn 167, Issue 5, 2014, Pages 660-665

  Whitlock, Richard ^a   Teoh, Kevin ^a   Vincent, Jessica ^a   Devereaux, P J ^a   Lamy, Andre ^a   Paparella, Domenico ^b   Zuo, Yunxia ^c   Sessler, Daniel I ^d   Shah, Pallav ^e   Villar, Juan Carlos ^f   Karthikeyan, Ganesan ^g   Urrútia, Gerard ^h   Alvezum, Alvaro ⁱ   Zhang, Xiaohe ^a   Abbasi, Seyed Hesameddin ^j   Zheng, Hong ^k   Quantz, Mackenzie ^l   Yared, Jean Pierre ^d   Yu, Hai ^c   Noiseux, Nicolas ^m   Yusuf, Salim ^a   more..

^a HAMILTON HEALTH SCIENCES   (Canada)

^b UNIVERSITY OF BARI   (Italy)

^c SICHUAN UNIVERSITY   (China)

^d LERNER RESEARCH INSTITUTE   (United States)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

^f FUNDACIÓN CARDIOINFANTIL INSTITUTO DE CARDIOLOGÍA   (Colombia)

^g ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^h CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

ⁱ INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^j TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^k XINJIANG MEDICAL UNIVERSITY   (China)

^l LONDON HEALTH SCIENCES CENTRE   (Canada)

^m CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; METHYLPREDNISOLONE; PLACEBO;

AGED; ARTICLE; BLEEDING; CARDIAC PATIENT; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORTICOSTEROID THERAPY; DELIRIUM; EUROSCORE; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART SURGERY; HUMAN; INSULIN TREATMENT; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; TREATMENT OUTCOME; WOUND COMPLICATION;

AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; CAUSE OF DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEART DISEASES; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; WORLD HEALTH;

EID: 84899572786     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.01.018     Document Type: Article

References (64)

1. G. Asimakopoulos et al. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass Ann Thorac Surg 68 3 1999 1107 1115
2. E.M. Boyle Jr. et al. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response Ann Thorac Surg 63 1 1997 277 284
3. C.F. Mojcik, and J.H. Levy Aprotinin and the systemic inflammatory response after cardiopulmonary bypass Ann Thorac Surg 71 2 2001 745 754
4. D. Paparella, T.M. Yau, and E. Young Cardiopulmonary bypass induced inflammation: pathophysiology and treatment Eur J Cardiothorac Surg 21 2 2002 232 244
5. M.A. Chaney Corticosteroids and cardiopulmonary bypass: a review of clinical investigations Chest 121 3 2002 921 931
6. J.K. Kirklin, and D.C. McGiffin Early complications following cardiac surgery Cardiovasc Clin 17 3 1987 321 343
7. K.H. Teoh et al. Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery Circulation 92 9 Suppl 1995 II347 II353
8. J.L. Vincent, S. Wan, and A.P. Yim Steroids in cardiopulmonary bypass Crit Care Med 28 9 2000 3373 3374
9. J.K. Kirklin et al. Complement and the damaging effects of cardiopulmonary bypass J Thorac Cardiovasc Surg 86 6 1983 845 857
10. M. Levi et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints Lancet 354 9194 1999 1940 1947
11. D. Royston Preventing the inflammatory response to open-heart surgery: the role of aprotinin and other protease inhibitors Int J Cardiol 53 Suppl. 1996 S11 S37
12. F.D. Rubens, and T. Mesana The inflammatory response to cardiopulmonary bypass: a therapeutic overview Perfusion 19 Suppl. 1 2004 S5 S12
13. S. Wan et al. Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients Am Heart J 133 3 1997 335 339
14. R.P. Whitlock et al. Pro: steroids should be used for cardiopulmonary bypass J Cardiothorac Vasc Anesth 19 2 2005 250 254
15. R. Ascione et al. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass Ann Thorac Surg 69 4 2000 1198 1204
16. V. Gulielmos et al. Interleukin-1, interleukin-6 and myocardial enzyme response after coronary artery bypass grafting - a prospective randomized comparison of the conventional and three minimally invasive surgical techniques Eur J Cardiothorac Surg 18 5 2000 594 601
17. S.M. Wildhirt et al. Reduction of systemic and cardiac adhesion molecule expression after off-pump versus conventional coronary artery bypass grafting Shock 16 Suppl. 1 2001 55 59
18. M.A. Chaney et al. Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation Anesth Analg 87 1 1998 27 33
19. M.A. Chaney et al. Methylprednisolone does not benefit patients undergoing coronary artery bypass grafting and early tracheal extubation J Thorac Cardiovasc Surg 121 3 2001 561 569
20. R.M. Engelman et al. Influence of steroids on complement and cytokine generation after cardiopulmonary bypass Ann Thorac Surg 60 3 1995 801 804
21. J.P. Gott et al. Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategies Ann Thorac Surg 66 3 1998 747 753 [discussion 753-4]
22. P. Halvorsen et al. The effect of dexamethasone on side effects after coronary revascularization procedures Anesth Analg 96 6 2003 1578 1583 [table of contents]
23. E.D. Verrier et al. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial JAMA 291 19 2004 2319 2327
24. R.A. Bronicki et al. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children Ann Thorac Surg 69 5 2000 1490 1495
25. M.A. Chaney, and M.P. Nikolov Methylprednisolone and the systemic inflammatory response syndrome Anesth Analg 89 5 1999 1333
26. P.A. Checchia et al. Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass Crit Care Med 31 6 2003 1742 1745
27. L.H. Coffin et al. Ineffectiveness of methylprednisolone in the treatment of pulmonary dysfunction after cardiopulmonary bypass Am J Surg 130 5 1975 555 559
28. R.H. Dietzman et al. The use of methylprednisolone during cardiopulmonary bypass. A review of 427 cases J Thorac Cardiovasc Surg 69 6 1975 870 873
29. S.R. El Azab et al. Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery Br J Anaesth 88 4 2002 496 501
30. D.C. Fecht et al. Beneficial effects of methylprednisolone in patients on cardiopulmonary bypass Circ Shock 5 4 1978 415 422
31. M.P. Fillinger et al. Glucocorticoid effects on the inflammatory and clinical responses to cardiac surgery J Cardiothorac Vasc Anesth 16 2 2002 163 169
32. G.E. Hill et al. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans J Thorac Cardiovasc Surg 110 6 1995 1658 1662
33. N.J. Jansen et al. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass J Thorac Cardiovasc Surg 102 4 1991 515 525
34. P.G. Jorens et al. Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone Am Rev Respir Dis 148 4 1993 890 895
35. T. Kawamura et al. Methylprednisolone inhibits increase of interleukin 8 and 6 during open heart surgery Can J Anaesth 42 5 1995 399 403
36. T. Kawamura et al. Influence of methylprednisolone on cytokine balance during cardiac surgery Crit Care Med 27 3 1999 545 548
37. E. Kilger et al. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery Crit Care Med 31 4 2003 1068 1074
38. H. Mayumi et al. Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass Ann Thorac Surg 63 1 1997 129 137
39. J.R. Morton et al. Effect of methylprednisolone on myocardial preservation during coronary artery surgery Am J Surg 131 4 1976 419 422
40. M.L. Moses et al. Effect of corticosteroid on the acidosis of prolonged cardiopulmonary bypass J Surg Res 6 8 1966 354 360
41. Z. Niazi et al. Effects of glucocorticosteroids in patients undergoing coronary artery bypass surgery Chest 76 3 1979 262 268
42. G. Rao et al. The effects of methylprednisolone on the complications of coronary artery surgery Vasc Surg 11 1 1977 1 7
43. R.L. Replogle, A.B. Gazzaniga, and R.E. Gross Use of corticosteroids during cardiopulmonary bypass: possible lysosome stabilization Circulation 33 4 Suppl 1966 I86 I92
44. V. Rumalla et al. The effects of glucocorticoid therapy on inflammatory responses to coronary artery bypass graft surgery Arch Surg 136 9 2001 1039 1044
45. U.P. Schurr et al. Preoperative administration of steroids: influence on adhesion molecules and cytokines after cardiopulmonary bypass Ann Thorac Surg 72 4 2001 1316 1320
46. P. Tassani et al. Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures? J Cardiothorac Vasc Anesth 13 2 1999 165 172
47. M.A. Thompson, and M.P. Broadbent Methylprednisolone prior to cardiopulmonary bypass Anaesthesia 35 4 1980 345 353
48. L.H. Toledo-Pereyra et al. Steroids in heart surgery: a clinical double-blind and randomized study Am Surg 46 3 1980 155 160
49. A. Turkoz et al. The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery J Cardiothorac Vasc Anesth 15 5 2001 603 610
50. T. von Spiegel et al. Effects of dexamethasone on intravascular and extravascular fluid balance in patients undergoing coronary bypass surgery with cardiopulmonary bypass Anesthesiology 96 4 2002 827 834
51. J. Wilson, W. Young, and B. Miller Pulmonary cellular changes prevented or altered by methylprednisolone sodium succinate Fed Proc 30 1971
52. J.P. Yared et al. Effects of single dose, postinduction dexamethasone on recovery after cardiac surgery Ann Thorac Surg 69 5 2000 1420 1424
53. M. Yilmaz et al. Effect of low-dose methyl prednisolone on serum cytokine levels following extracorporeal circulation Perfusion 14 3 1999 201 206
54. J.M. Dieleman et al. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial JAMA 308 17 2012 1761 1767
55. S.A. Nashef et al. European system for cardiac operative risk evaluation (EuroSCORE) Eur J Cardiothorac Surg 16 1 1999 9 13
56. C. Wang et al. Validation of the European system for cardiac operative risk evaluation (EuroSCORE) in Chinese heart valve surgery patients J Heart Valve Dis 19 1 2010 21 27
57. M. Malik et al. Is EuroSCORE applicable to Indian patients undergoing cardiac surgery? Ann Card Anaesth 13 3 2010 241 245
58. R.P. Whitlock et al. Pulse low dose steroids attenuate post-cardiopulmonary bypass SIRS SIRS I J Surg Res 132 2 2006 188 194
59. K.M. Ho, and J.A. Tan Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis Circulation 119 14 2009 1853 1866
60. S.K. Inouye, C.H. van Dyck, and C.A. Alessi et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium Ann Intern Med 113 1990 941 948
61. Group, K.D.I.G.O.K.A.K.I.W KDIGO clinical practice guideline for acute kidney injury Kidney Inter 2012 1 138
62. R.P. Whitlock et al. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials Eur Heart J 29 21 2008 2592 2600
63. M. Mazumdar, A. Smith, and J. Bacik Methods for categorizing a prognostic variable in a multivariable setting Stat Med 22 4 2003 559 571
64. P.J. Devereaux et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery JAMA 307 21 2012 2295 2304